Recent News

By forming clots in tumors, immune cells aid lung cancer's spread

By forming clots in tumors, immune cells aid lung cancer's spread

Researchers led by UNC Lineberger's Chad Pecot, MD, report in the journal Nature Communications that for a particular subset of lung cancer tumors, there is a high prevalence of immune cells called inflammatory monocytes. These cells, which normally help to build clotting scaffolds to promote wound healing, also make it possible for tumor cells to migrate and spread to other parts of the body.

By forming clots in tumors, immune cells aid lung cancer's spread - Read More…

Commentary: Current evidence does not support call for more frequent colorectal cancer screening

Commentary: Current evidence does not support call for more frequent colorectal cancer screening

In an editorial published in JAMA, UNC Lineberger's Hanna Sanoff, MD, MPH, evaluated two studies that investigated whether higher-intensity testing for non-metastatic colorectal cancer is more effective.

Commentary: Current evidence does not support call for more frequent colorectal cancer screening - Read More…

Symposium showcases career options for scientists-in-training

Symposium showcases career options for scientists-in-training

UNC Lineberger's second annual Integrated Training in Cancer Model Systems Director’s Career Symposium introduces scientists-in-training to a variety of career paths.

Symposium showcases career options for scientists-in-training - Read More…

Bladder cancer model could pave the way for better drug efficacy studies

Bladder cancer model could pave the way for better drug efficacy studies

In the journal Cancer Research, UNC Lineberger’s William Y. Kim, MD, Benjamin G. Vincent, MD, and colleagues reported they have developed a mouse model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer. The researchers said this model may help them to determine which patients may respond to immunotherapy treatments called checkpoint inhibitors.

Bladder cancer model could pave the way for better drug efficacy studies - Read More…